Trials / Active Not Recruiting
Active Not RecruitingNCT04541563
Fisher Wallace Neurostimulation & Depression Study
Neurostimulation & Depression Study
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 175 (estimated)
- Sponsor
- ProofPilot · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Accepted
Summary
Examine the safety and effectiveness of the Fisher Wallace Cranial Electrotherapy Stimulator Device on Major Depressive Disorder using two 20-minute per day treatment sessions over eight weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Fisher Wallace Cranial Electrotherapy Stimulator Device | Fisher Wallace Stimulator®, a patented cranial electrotherapy stimulation device that was cleared by the FDA in 1991 for the treatment of depression, anxiety and insomnia. |
Timeline
- Start date
- 2020-08-24
- Primary completion
- 2021-03-30
- Completion
- 2021-11-30
- First posted
- 2020-09-09
- Last updated
- 2021-02-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04541563. Inclusion in this directory is not an endorsement.